ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for charts Register for streaming realtime charts, analysis tools, and prices.

CRDA Croda International Plc

4,576.00
-43.00 (-0.93%)
Last Updated: 08:28:23
Delayed by 15 minutes
Share Name Share Symbol Market Type Share ISIN Share Description
Croda International Plc LSE:CRDA London Ordinary Share GB00BJFFLV09 ORD 10.609756P
  Price Change % Change Share Price Bid Price Offer Price High Price Low Price Open Price Shares Traded Last Trade
  -43.00 -0.93% 4,576.00 4,576.00 4,581.00 4,622.00 4,576.00 4,622.00 6,030 08:28:23
Industry Sector Turnover Profit EPS - Basic PE Ratio Market Cap
Chemicals & Chem Preps, Nec 1.69B 171M 1.2246 37.59 6.43B
Croda International Plc is listed in the Chemicals & Chem Preps sector of the London Stock Exchange with ticker CRDA. The last closing price for Croda was 4,619p. Over the last year, Croda shares have traded in a share price range of 4,018.00p to 7,030.00p.

Croda currently has 139,635,400 shares in issue. The market capitalisation of Croda is £6.43 billion. Croda has a price to earnings ratio (PE ratio) of 37.59.

Croda Share Discussion Threads

Showing 601 to 625 of 700 messages
Chat Pages: 28  27  26  25  24  23  22  21  20  19  18  17  Older
DateSubjectAuthorDiscuss
14/3/2022
22:44
Thanks for the insight.
commuter10
14/3/2022
19:19
When a company undergoes a divestment and an overhaul in corporate strategy, there will always be a need to shuffle the board and, in some cases, may be surplus to requirements.

New skills are needed for the new health-focused tragedy. Skincare is likely to be at the forefront of new business, with Sederma in the spotlight.

Keep an eye on its partnership with SBTX. It is about to shake the foundations of the cosmetics world with new science, not 9 out of 10 cats preferred…

elrico
10/3/2022
15:13
Another Director resigning & selling their shares today.

The management isn't looking to stable at present but not sure why?

tHe latest results looked o.k. on the face of it.

Any ideas anyone?

commuter10
18/2/2022
16:43
It seems to me that either there is some really bad news out there (unlikely IMHO) or those who are shorting are making a last heave to push the price down before they have to buy back which I will be very surprised if they don't do before results on 1st March.
The only real unknown is the Ukraine situation which could drive everything down.
We still have only one broker recommending a sell, 3 strong buys and 10 holds.
So I'm hanging on. Good luck all (unless you're shorting..).

mercury123
09/2/2022
17:24
Many thanks Mercury & a much better day to day. Let's hope it's very positive.
commuter10
09/2/2022
17:18
Worth waiting for the results on 1st March. Provided they don't disappoint we should see a very strong rebound
mercury123
08/2/2022
18:57
Current price is abt 30 years worth of current earnings
riskonricky
08/2/2022
18:20
Does anyone know what's going on here please?
commuter10
08/2/2022
15:54
Guess that 7758 was not bottom then , continuing to fall, maybe this is going back to a £50 share again?
wad collector
25/1/2022
11:54
Does anyone know exactly what royal Bank Of Canada is doing with their shares?

The notification doessn't really show if they were buying or selling.

They obviously by Stock Exchange regulations have to notify shareholders if their holding % changes but it's not clear to me what they're transaction is.

commuter10
25/1/2022
10:40
Looking at the numbers again , with current P/E of 50 , I think it depends on why you view the recent rise happened.
I am impressed by the nanoparticle supply market. Rna is going to become a much bigger therapeutic option than it is currently , and although the big money will go to the developers, the demand for the nanoparticles will only rise. And there is quite a high bar to entry for their manufacture. That said, Croda may not dominate the supply market as the Chinese must be looking to the sector.
I am gambling that we have reached bottom and just added at 77.58.

wad collector
24/1/2022
18:12
Down another 5% today and nearly 30% since the market re-opened after Christmas.

Nothing has happened so far as I can tell, fundamentally, so this looks like a major correction.

Not far to go in percentage terms before it drops further than March 2020. There is nothing like it in its last ten years of trading.

Do I bail out or have faith? It has to hit a bottom, and it's a fundamentally solid company.

cell1919
19/1/2022
14:07
Unfortunately Not Cell & would like to know as wellwhy such a rapid decline for a major Blue Chip Company. Let's hope there's a correction on the way.
commuter10
19/1/2022
08:59
With a P/E of 56 it clearly isn't an income play, maybe it should still be a £50 share after covid chaos has settled?
wad collector
18/1/2022
14:55
Good afternoon.

Can anyone cast any light on why the shares have fallen so rapidly and mercilessly? I think there was a feeling that there was some overheating but it's been consistent carnage since the turn of the year.

Apart from yesterday the shares have fallen every day since Christmas and there doesn't seem to be a bottom. Losing nearly a quarter of your value when there appears to be nothing major in the pipeline seems more than a simple correction.

In the same time period the 100 has increased around 2%, but that figure in itself will have been dragged back a bit due to the fall in Croda's shares.

Thanks for any insight that might be available.

cell1919
17/1/2022
16:17
It looks like that the Norweigan Bank had to declare it's holding size.

I assume as it was buying more shares ehich makes sendse with the price rising today.

It's been a rocky 2-3 months for this share though.

commuter10
17/1/2022
15:02
No, that's got me beat :-)
philanderer
17/1/2022
14:54
Hi Phil, makes a change from WTB! Thanks for the news above. Any idea what's happening today with FCA declaration please?
commuter10
23/12/2021
15:48
Croda: Vaccine boost offsets industrial sale


There was some disappointment at the decision of chemicals specialist Croda (CRDA) to sell its bio-based industrial business, but the stock remains well ahead this year thanks to its vaccine exposure, according to Hargreaves Lansdown.

The group reported the sale of its bio-based industrial business to US firm Cargill Velocity for £778m following a review of this part of the business. The price tag has, however, disappointed some investors, as the shares eased 0.4% to £99.42.

Analyst Susannah Streeter said it was still one of the FTSE 100’s best performers in 2021, up 48% over the year thanks to strong first-half results and full-year profits forecast to beat earlier expectations.

‘The extent to which Croda is benefiting from the ongoing vaccine boom has become clear over recent months and it’s down to its investment in innovative technologies,’ she said.

‘It supplies lipid nanoparticles for Pfizer’s mRNA technology and given the demand for booster jabs, that area of life sciences is bounding along.’

Streeter said even when vaccine demand wanes there will still be demand for ‘a broader range of use of its products in medical treatments like oncology’.

‘Recovery in consumer markets has also helped its personal care sector which focuses on ingredients for skin, hair, and cosmetic products and the focus on sustainability should help drive sales among an increasingly eco-conscious customer base,’ said Streeter.


citywire.com

philanderer
10/12/2021
16:22
Blimy I keep meeting the same people - lol. We must be using the same software.
netcurtains
09/12/2021
11:51
£115???
Seems conservative. At current TTM P/E of 57, assuming it keeps up, that would imply EPS of about 200p for a £115 share price
Hmmm, surely a bit more EPS gain than that?

From the Interims:
"We now expect 2021 full year adjusted profit before tax to be significantly ahead of current expectations. Subject to there being no material change in current market conditions, we expect a similar phasing of profit between the first and second half periods as seen in previous years."

sogoesit
08/12/2021
19:39
That Citigroup tp is weird :-)


Croda International PLC (LSE:CRDA) has climbed 2.04% to 10,260p after positive news on the effect of the Pfizer/BioNTech vaccine on the omicron variant. Croda is a lipid supplier to Pfizer for the vaccine.

An upgrade by UBS analysts from neutral to buy with a target price raised from 9000p to 11,500p has also helped Croda.

proactiveinvestors.co.uk

philanderer
08/12/2021
19:30
In broker note action, Croda was boosted 2.24% by an upgrade to ‘buy’ from ‘neutral’; at UBS.


ADVFN market report

philanderer
08/12/2021
16:52
Croda International (CRDA)
Citigroup Buy 9,500.00p 9,500.00p Reiteration

I love brokers and updates, they put as Buy with a £9.50 target price and yet the current price is £10.30!

wad collector
03/12/2021
09:11
People who have read wording of gdr rns on Monday expecting another rns with in days on new fast ,POC covid test.
capitol2
Chat Pages: 28  27  26  25  24  23  22  21  20  19  18  17  Older

Your Recent History

Delayed Upgrade Clock